- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04497441
Netizens' Perception of COVID-19 Information & Information Sources.
Perceptions of Netizens Regarding COVID-19 Information & Information Sources: A Cross Sectional Study
COVID-19 Infection was characterized as a Pandemic by WHO on the 11th of March 2020.1 After this there were all possible worldwide efforts to increase awareness in the general population about the COVID-19 Infection signs, symptoms, mode of transmission and prevention. The information was spread across all possible mass media communication channels. There were constant updates regarding the data of newly infected cases, deaths, and recoveries. This cross sectional study is conducted with the following objectives:
- To understand the netizens perception regarding the sources of information available on COVID-19.
- To understand the netizens populations perception regarding the available information on COVID-19.
Study Overview
Status
Intervention / Treatment
Detailed Description
Mass media plays a significant role in public outreach and create awareness. Various mass media has their individual reach to the general public. In the current world of information technology availability of information is not an issue. There is in fact excessive availability of information. What makes a big difference is that RIGHT information delivery on RIGHT time and within RIGHT time. After WHO characterized COVID-19 infection as pandemic, mass media played a significant role in creating awareness regarding COVID-19 infection signs, symptoms, mode of transmission and its prevention. There were constant updates in various mass media regarding the data of newly infected cases, deaths, and recoveries. COVID-19 Pandemic has created fears, anxiety, and worries among the general population. There was information given to general public regarding treatment drugs and possibility of vaccine for COVID-19 infection. This created a ray of hope in many. So information in various mass media sources had different types of impact on general population thoughts.
This cross sectional study is conducted with the following objectives:
- To understand the general populations perception regarding the sources of information available on COVID-19.
- To understand the general populations perception regarding the available information on COVID-19.
This Cross sectional study utilizes an electronic google form to get responses from netizens of Al Qassim province of Saudi Arabia regarding the perception of COVID-19 information and information sources. All the questions in the survey are compulsory answerable questions. The settings in the google form are set so that a single respondent can limit the survey response to single time. The Survey Questionnaire contained following sections:
Section I: Minimum required personal details Section II: 10 Questions regarding the source of COVID-19 information Section III: 6 Questions regarding perception of the COVID-19 information
The questionnaire also carried the following disclaimer:
"This Survey will not Collect your Name, Email, Location, and Phone number. We pledge that the data obtained by this survey is for Educational purpose & scientific knowledge enhancement only. The data will not be transferred or shared with any other third party for commercial interest."
The very first part of the Questionnaires seeks responders' consent for giving responses to the survey questions. participation Section II & III contained all closed ended questions. The Google form link is shared to the netizens of Al Qassim province across relevant Social media platforms.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Bugude Shiva Shankar, MDS
- Phone Number: +966163020523
- Email: S.ggg@qu.edu.sa
Study Contact Backup
- Name: Shiva Shankar Bugude, MDS
- Phone Number: +966 531476028
- Email: S.ggg@qu.edu.sa
Study Locations
-
-
Al Qassim
-
Ar Rass, Al Qassim, Saudi Arabia, 51921
- Recruiting
- Dr Bugude Shiva Shankar
-
Contact:
- Bugude Shiva Shankar, MDS
- Phone Number: +966163020523
- Email: S.ggg@qu.edu.sa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male and Female Human volunteer internet users who belong &/or reside in Al Qassim province region of Saudi Arabia.
- Volunteers should be major by age (18 years and above).
Exclusion Criteria:
- Minor age group (<18 years) subjects are excluded from the study.
- Internet users who have preexisting phobia and/or anxiety mental conditions are excluded from the study.
- Internet users who are currently under treatment for their preexisting phobia and/or anxiety mental conditions are excluded from the study.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Netizens
Internet users in Al Qassim province region are the target study population for this study.
This Cross sectional study utilizes an electronic google form to get responses from netizens of Al Qassim province of Saudi Arabia regarding the perception of COVID-19 information and information sources.
All the questions in the survey are compulsory answerable questions.
The settings in the google form are set so that a single respondent can limit the survey response to single time.
The Google form link is shared to the netizens of Al Qassim province across relevant Social media platforms.
|
This Cross sectional study utilizes an electronic google form to get responses from netizens of Al Qassim province of Saudi Arabia regarding the perception of COVID-19 information and information sources. All the questions in the survey are compulsory answerable questions. The settings in the google form are set so that a single respondent can limit the survey response to single time. The Survey Questionnaire contained following sections: Section I: Minimum required personal details Section II: 10 Questions regarding the source of COVID-19 information Section III: 6 Questions regarding perception of the COVID-19 information The very first part of the Questionnaires seeks responders' consent for giving responses to the survey questions. participation Section II & III contained all closed ended questions. The Google form link is shared to the netizens of Al Qassim province across relevant Social media platforms. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Netizens' perception of the Sources of COVID-19 information
Time Frame: 11th of August 2020
|
Assessing the perception regarding the Sources of COVID-19 information among netizens in Al Qassim province using a 10 open ended Questionnaire.
Descriptive statistics will be used to present the data.
|
11th of August 2020
|
Netizens' perception on COVID-19 information
Time Frame: 11th of August 2020
|
Assessing the perception regarding COVID-19 information among netizens in Al Qassim province using a 6 open ended Questionnaire.
Descriptive statistics will be used to present the data.
|
11th of August 2020
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation of Age and the Frequency of checking COVID-19 information updates
Time Frame: 11th of August 2020
|
The survey data will be statistically analyzed to check for the Correlation of Age and the Frequency of checking COVID-19 information updates.
The data obtained from the survey will be subjected to appropriate analytical statistical tests to understand the correlation.
A p-value of <0.05 is considered statistically significant correlation of the variables analysed.
|
11th of August 2020
|
Correlation of Gender and the Frequency of checking COVID-19 information updates
Time Frame: 11th of August 2020
|
The survey data will be statistically analyzed to check for the Correlation of Gender and the Frequency of checking COVID-19 information updates.
The data obtained from the survey will be subjected to appropriate analytical statistical tests to understand the correlation.
A p-value of <0.05 is considered statistically significant correlation of the variables analysed.
|
11th of August 2020
|
Correlation of Age and the perception of newly infected COVID-19 cases information update
Time Frame: 11th of August 2020
|
The survey data will be statistically analyzed to check for the Correlation of Age and the perception of newly infected COVID-19 cases information update.
The data obtained from the survey will be subjected to appropriate analytical statistical tests to understand the correlation.
A p-value of <0.05 is considered statistically significant correlation of the variables analysed.
|
11th of August 2020
|
Correlation of Age and the perception of COVID-19 deaths information update
Time Frame: 11th of August 2020
|
The survey data will be statistically analyzed to check for the Correlation of Age and the perception of COVID-19 deaths information update.
The data obtained from the survey will be subjected to appropriate analytical statistical tests to understand the correlation.
A p-value of <0.05 is considered statistically significant correlation of the variables analysed.
|
11th of August 2020
|
Correlation of Age and the perception of COVID-19 Vaccine information update
Time Frame: 11th of August 2020
|
The survey data will be statistically analyzed to check for the Correlation of Age and the perception of COVID-19 Vaccine information update.
The data obtained from the survey will be subjected to appropriate analytical statistical tests to understand the correlation.
A p-value of <0.05 is considered statistically significant correlation of the variables analysed.
|
11th of August 2020
|
Correlation of Age and the perception of COVID-19 treatment medicines/drugs information update
Time Frame: 11th of August 2020
|
The survey data will be statistically analyzed to check for the Correlation of Age and the perception of COVID-19 treatment medicines/drugs information update.
The data obtained from the survey will be subjected to appropriate analytical statistical tests to understand the correlation.
A p-value of <0.05 is considered statistically significant correlation of the variables analysed.
|
11th of August 2020
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Bugude Shiva Shankar, MDS, College of Applied Health Sciences - Al Rass
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- QassimU3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital ZürichEnrolling by invitation
-
Alexandria UniversityCompleted
Clinical Trials on Electronic Survey questionnaire
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingEndocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer PatientsBreast CarcinomaUnited States
-
Brno University HospitalEuropean Society of Intensive Care Medicine; European Society of Anaesthesiology...CompletedSevere COVID-19Czechia
-
Brno University HospitalEuropean Society of Anaesthesiology (ESA)Completed
-
UNC Lineberger Comprehensive Cancer CenterCompletedStem Cell Transplantation, HematopoieticUnited States
-
Trate - Tratamentos EspecializadosUnknown
-
Université de SherbrookeFondation VitaeNot yet recruitingCommunication, MultidisciplinaryCanada
-
Massachusetts Institute of TechnologyMillennium Pharmaceuticals, Inc.CompletedPatient Reported Outcome Measures | ComplianceUnited States
-
KU LeuvenLiantis; Mensura; Belgian Association for Occupational Physicians; IDEWE Occupational...CompletedOccupational Health | Surveys and Questionnaires | ScreeningBelgium
-
University of Sao Paulo General HospitalCompletedCOVID-19 | SARS-CoV 2 | Corona Virus Infection | Sedentary BehaviorBrazil